HEADINVEST, LLC quarter change: Foreign Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, HEADINVEST, LLC opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was ONCOLYTICS BIOTECH INC (-$37,941); the largest decrease was ONCOLYTICS BIOTECH INC (-$37,941).
- ONCOLYTICS BIOTECH INC: Country of operation —; Class COM NEW; Shares 2026-03-31 44,700; Shares 2026-06-30 0.
Two Form 13F-HR filings compared (SEC CIK 1372130): 2026-03-31 (filed 2026-05-15) and 2026-06-30 (filed 2026-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| University of Illinois Foundation | United States | $0.487B | 31 |
| Beacon Bank & Trust | United States | $0.488B | 252 |
| Kendall Capital Management | United States | $0.488B | 231 |
| Rosenberg Matthew Hamilton | United States | $0.488B | 800 |
| CONTRAVISORY INVESTMENT MANAGEMENT, INC. | United States | $0.488B | 366 |
| Aljian Capital Management, LLC | United States | $0.487B | 131 |
| Summit Creek Advisors LLC | United States | $0.487B | 65 |
| Ackerman Capital Advisors, LLC | United States | $0.488B | 115 |
| Clarity Wealth Advisors, LLC | United States | $0.486B | 108 |
| PCM Encore, LLC | United States | $0.486B | 445 |